Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

OnlyRx vs Ro

OnlyRx
Graded #311

Lower grade

vs+19.300000000000004
Ro
Graded #38

Higher grade

The verdict

Ro takes it — 80.2/100 to 60.9/100.

Ro grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A heavyweight platform with brand-name access — but opaque compounded pricing drags its score.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRo +26
42
68
Dose & formulationOnlyRx +2
88
86
Clinical oversightRo +14
72
86
Labs & monitoringRo +30
52
82
FulfillmentRo +32
52
84
Contract termsRo +25
55
80
OnlyRx · left barRo · right bar

The numbers

MetricOnlyRxRo
WeighScore60.9/10080.2/100
GradeCB−
Scorecard rank#311#38
Semaglutide$179/mo (starting dose, promotional rate, compounded)Not disclosed
Tirzepatide$249/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedMulti-state
Brand-name accessYesYes
Oral / sublingualYesYes
OnlyRx

Graded #311 · C

Strengths

  • Four-pharmacy network: Belmar, Strive, Epiq Scripts, and Casa Pharma RX
  • Named prescribers on the public site: Dr. Carr (MD), Dr. Tenbrink (MD), Dr. Italia (MD), Dr. Mansour (DO)
  • Oral disintegrating tablet (ODT) form for both semaglutide and tirzepatide — good for needle-averse patients
  • Pricing, drug list, pharmacy partners, and physician roster all visible on the public site
  • LegitScript Certified

Where it loses points

  • Promo pricing ($179 semaglutide injection) is prominent, but post-promo maintenance pricing isn't shown
  • No titration-ladder pricing — you can't see costs at 1.0 mg or 2.4 mg maintenance
  • Refund / cancellation policy not stated on the homepage
  • Lab-work requirement not stated
  • Operating corporate entity not disclosed
Ro

Graded #38 · B−

Strengths

  • Brand-name access + insurance support
  • Oral options
  • Well-funded platform

Where it loses points

  • Does not disclose compounded pricing up front
  • Premium positioning

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard